Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Reported events included nausea, vomiting, and diarrhea, consistent with the broader GLP-1 receptor agonist class
Our customer service team will reach out for more information as needed
Key Takeaways Retatrutide is an investigational triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously
Walking is the most accessible option and can be started immediately regardless of fitness level
Improves nerve function and may aid in the management of neuropathic symptoms
US$ 20.14
US$ 20.47
US$ 28.82
